enforcement
CGMP Violations at LGM Pharma Solutions
A 5/11-5/18 FDA inspection at the LGM Pharma Solutions drug manufacturing facility in Irvine, CA, identified current good manufacturing practice (CGMP) violations in the firm’s manufacturing of finished drugs. An 11/2 Warning Letter says the specific violations were: * failure to thoroughly investigate any unexplained discrepancy